Compare Novo Nordisk A/S (NVO) vs Rivian Automotive, Inc. (RIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Rivian Automotive, Inc. — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Rivian Automotive, Inc. trades at $17.75 (market cap $24.95B). The key difference: Novo Nordisk A/S is far larger — about 8.8× Rivian Automotive, Inc.'s market cap, and Novo Nordisk A/S pays a 3.63% dividend while Rivian Automotive, Inc. pays none. Which is the better fit depends on your goals.
| NVO | RIVN | |
|---|---|---|
Market Cap | $220.53B | $24.95B |
Sector | Health | Consumer Cyclical |
52-Week High | $71.70 | $22.45 |
52-Week Low | $35.29 | $11.64 |
Enterprise Value | $239.49B | $26.70B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Rivian Automotive, Inc.
Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →
